- Home
- Publications
- Publication Search
- Publication Details
Title
The Genetic Complexity of Prostate Cancer
Authors
Keywords
-
Journal
Genes
Volume 11, Issue 12, Pages 1396
Publisher
MDPI AG
Online
2020-11-25
DOI
10.3390/genes11121396
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Androgen receptor variant-driven prostate cancer II: advances in laboratory investigations
- (2020) Changxue Lu et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry
- (2020) Jiao Yuan et al. PLoS Genetics
- Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes
- (2020) Jennifer L. Beebe-Dimmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Loss of DNA mismatch repair proteins in prostate cancer
- (2020) Meenal Sharma et al. MEDICINE
- Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies
- (2020) Laura S. Graham et al. PLoS One
- A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data
- (2020) Minh-Phuong Huynh-Le et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Effects of replacing PSA with Stockholm3 for diagnosis of clinically significant prostate cancer in a healthcare system – the Stavanger experience
- (2020) Eirik Viste et al. SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE
- Germline sequencing DNA repair genes in 5,545 men with aggressive and non-aggressive prostate cancer
- (2020) Burcu F Darst et al. JNCI-Journal of the National Cancer Institute
- Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer
- (2020) Maha Hussain et al. NEW ENGLAND JOURNAL OF MEDICINE
- SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG ‐rearranged prostate cancer
- (2019) Silvia Hernández‐Llodrà et al. PROSTATE
- Clinical Utility of the Nuclear-localized AR-V7 Biomarker in Circulating Tumor Cells in Improving Physician Treatment Choice in Castration-resistant Prostate Cancer
- (2019) Ryon P. Graf et al. EUROPEAN UROLOGY
- Integrative clinical transcriptome analysis reveals TMPRSS2‐ERG dependency of prognostic biomarkers in prostate adenocarcinoma
- (2019) Julia S. Gerke et al. INTERNATIONAL JOURNAL OF CANCER
- EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)
- (2019) Thomas B.L. Lam et al. EUROPEAN UROLOGY
- Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of a non-aggressive disease
- (2018) A Kamoun et al. ANNALS OF ONCOLOGY
- Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations
- (2018) René Böttcher et al. BMC CANCER
- Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
- (2018) Yi-Mi Wu et al. CELL
- CTC-derived AR-V7 detection as a prognostic and predictive biomarker in advanced prostate cancer
- (2018) Diogo A. Bastos et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017
- (2018) Veda N. Giri et al. JOURNAL OF CLINICAL ONCOLOGY
- Synthetic lethal therapies for cancer: what’s next after PARP inhibitors?
- (2018) Alan Ashworth et al. Nature Reviews Clinical Oncology
- Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants
- (2018) Tokhir Dadaev et al. Nature Communications
- Cumulative Evidence for Relationships Between 8q24 Variants and Prostate Cancer
- (2018) Yu Tong et al. Frontiers in Physiology
- Mutational Profile of Aggressive, Localised Prostate Cancer from African Caribbean Men Versus European Ancestry Men
- (2018) Laurie Tonon et al. EUROPEAN UROLOGY
- Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer
- (2018) H. Ballentine Carter et al. EUROPEAN UROLOGY
- Germline variation at 8q24 and prostate cancer risk in men of European ancestry
- (2018) Marco Matejcic et al. Nature Communications
- Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade
- (2018) Wassim Abida et al. JAMA Oncology
- Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death
- (2017) Rong Na et al. EUROPEAN UROLOGY
- Prognostic outlier genes for enhanced prostate cancer treatment
- (2017) Hyun Kim et al. Future Oncology
- NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
- (2016) Mary B. Daly et al. Journal of the National Comprehensive Cancer Network
- Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
- (2016) Colin C. Pritchard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer
- (2015) Gretchen K. Hubbard et al. CANCER RESEARCH
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- The Molecular Taxonomy of Primary Prostate Cancer
- (2015) Adam Abeshouse et al. CELL
- Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer
- (2015) A. A. Azad et al. CLINICAL CANCER RESEARCH
- SPOP Mutations in Prostate Cancer across Demographically Diverse Patient Cohorts
- (2015) Mirjam Blattner et al. NEOPLASIA
- SPINK1 Protein Expression and Prostate Cancer Progression
- (2014) R. Flavin et al. CLINICAL CANCER RESEARCH
- The emerging role of speckle-type POZ protein (SPOP) in cancer development
- (2014) Ram-Shankar Mani DRUG DISCOVERY TODAY
- RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1
- (2014) John R Prensner et al. LANCET ONCOLOGY
- Destruction of Full-Length Androgen Receptor by Wild-Type SPOP, but Not Prostate-Cancer-Associated Mutants
- (2014) Jian An et al. Cell Reports
- Genetic markers associated with early cancer-specific mortality following prostatectomy
- (2013) Wennuan Liu et al. CANCER
- A Gain-of-Function Mutation in DHT Synthesis in Castration-Resistant Prostate Cancer
- (2013) Kai-Hsiung Chang et al. CELL
- Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas
- (2013) Kathryn P. Pennington et al. CLINICAL CANCER RESEARCH
- Tracking the clonal origin of lethal prostate cancer
- (2013) Michael C. Haffner et al. JOURNAL OF CLINICAL INVESTIGATION
- Nuclear PTEN Controls DNA Repair and Sensitivity to Genotoxic Stress
- (2013) C. Bassi et al. SCIENCE
- Concordance of Tumor Differentiation Among Brothers with Prostate Cancer
- (2012) K. Fredrik Jansson et al. EUROPEAN UROLOGY
- The DNA damage response and cancer therapy
- (2012) Christopher J. Lord et al. NATURE
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
- (2012) Christopher E Barbieri et al. NATURE GENETICS
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer
- (2011) A. Brandt et al. ANNALS OF ONCOLOGY
- Comparison of scores for bimodality of gene expression distributions and genome-wide evaluation of the prognostic relevance of high-scoring genes
- (2010) Birte Hellwig et al. BMC BIOINFORMATICS
- Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
- (2010) P. A. Watson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target
- (2009) Yu Chen et al. LANCET ONCOLOGY
- The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling
- (2009) Sari Tuupanen et al. NATURE GENETICS
- Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
- (2008) A Mitra et al. BRITISH JOURNAL OF CANCER
- TMPRSS2:ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis
- (2008) O. R. Saramaki et al. CLINICAL CANCER RESEARCH
- Concordance of Survival in Family Members With Prostate Cancer
- (2008) Kari Hemminki et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started